Analisis dan Penilaian Bisnis Perusahaan BUMN di Industri Farmasi: Studi Kasus Kimia Farma dan Indofarma Tahun 2006-2008
Keywords:performance, pharmaceutical, investments
The objective of this research were R to determine the financial ratios as a basis to describe the financial performance and compare stock prices to book value (PBV) and evaluate the rate of return between the two companies by using the Du Pont analysis, with the focus for pharmaceutical industries in Indonesia. The benefit to provide an overview of financial performance of both companies. Then predicted to prospective investors on the cheap or expensive a stock. Provide recommendations to potential investors to make investment decisions. The method used is the ratio method and the percentage sales method. The conclusion can be that the performance of Finance at PT Kimia Farma as part of Indonesian pharmaceutical industries largely increased from year to year, while PT Indofarma largely decreased. PT Indofarma stock price is cheaper than PT Kimia Farma. The rate of return is relatively stable PT Kimia Farma and PT Indofarma has decreased from year to year. For the moderate investor PT Kimia Farma is the right choice.
Munawir, S. (2002). Analisis laporan keuangan. Yogyakarta: Liberty.
Wild, J. J., dkk. (2008). Financial statement analysis: Buku 1. Jakarta: Salemba Empat.
Wild, J. J., dkk. (2008). Financial statement analysis: Buku 2. Jakarta: Salemba Empat.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License - Share Alike that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
All articles published Open Access will be immediately and permanently free for everyone to read and download. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows: Creative Commons Attribution-Share Alike (CC BY-SA)